Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Cantargia publishes interim report for third quarter 2020

Cantargia AB’s (”Cantargia”) interim report for the period January until September 2020 is now available on the company’s web page www.cantargia.com/en/investors/financial-reports.Significant events in the third quarter · Positive interim results presented from phase 2a study CANFOUR on combination therapy with CAN04 and chemotherapy in patients with non-small cell lung cancer.     Significant events after the end of the period · The first patient started treatment with CAN04 in a phase I study in the US investigating CAN04 in combination with pembrolizumab. · Recruitment of

A strong recovery, and we’re ready for 2021

· EBITDA for the quarter was SEK 27.0 million, double the figure from the previous quarter and on a level with the corresponding quarter in the previous year.  · Pronounced increase in sales in key European markets, for example Germany and Sweden. Allgon has reorganised and adapted aspects of its sales operation in order to use digital channels to safeguard its sales and service functions.  · Continued preparations to enable the organisation to manoeuvre around any restrictions brought about by the pandemic. If a second wave impacts the market significantly, we will be ready for it. ·

Interim report January – September 2020

The period in summary Third quarter July 1 – September 30, 2020 · Our marketing authorization application for Strangvac was submitted to the European Medicines Agency, EMA, at the end of February. During the third quarter, we have strengthened the dossier in the areas where EMA has asked for clarification. We are happy to report that we remain on track with our schedule and plan for a positive statement from EMA during the first half of 2021. · We focus on the preparations for the launch of Strangvac, which includes a distribution partner for Europe, outside regions where we

Today is the first day of trading in DanCann Pharma A/S shares and warrants at Spotlight Stock Market

Today is the first day of trading in DanCann Pharma A/S ("DanCann Pharma") shares and warrants of series TO 1. DanCann Pharma’s shares are traded under the ticker "DANCAN" with ISIN DK0061410487 and DanCann Pharma’s warrants of series TO 1 are traded under the ticker "DANCAN TO 1" with ISIN DK0061410560.DanCann Pharma was provided approximately DKK 30 million (before issue costs) in the oversubscribed IPO of units which resulted in more than 1 600 new shareholders. The total number of shares in DanCann Pharma is 20 730 800 shares and the share capital amount to DKK 777 405. In addition,

Mentice publishes the company’s interim report for the period July–September 2020

Two exciting acquisitions and strong performance in the medical device industry segment  Third quarter (July–September 2020) · Net sales amounted to 33.4 (29.3) MSEK. · Operating income for the period before depreciations (EBITDA) totalled 4.1 (-6.7) MSEK. · Net income for the period amounted to -0.3 (-9.0) MSEK. · Earnings per share (EPS) was -0.01 (-0.37) SEK. · Order intake amounted to 34.6 (24.4) MSEK. · Cash flow from operating activities totalled -6.2 (-16.2) MSEK. First nine months of the year (January–September 2020) · Net sales for the first nine

Klaria announces regulatory approval of the pivotal bioequivalence clinical study with Sumatriptan Alginate Film

Klaria has successfully completed regulatory review and has secured all necessary approvals to start the pivotal bioequivalence study with Sumatriptan Alginate Film.   The Medicines and Healthcare products Regulatory Agency (MHRA) have granted their approval of the study.  Klaria will now initiate the clinical study and the company reiterated the previously communicated timelines for the study, confirming that results are expected in Q1, 2021.  Additionally, review of the comprehensive EU development plan with the Swedish Medical Products Agency (acting as representative of the European

Gasum opens the Turku biogas plant, the first in Finland to produce liquefied biogas ─ The circular economy becomes a reality in the Turku region

Gasum strives actively to increase biogas production capacity by expanding and improving the efficiency of existing biogas plants and by increasing biogas procurement. The opening of the Turku biogas plant took place today. The biogas plant is the first in Finland to produce liquefied biogas for transport, industrial and maritime needs.Start-up of Finland’s first biogas plant producing liquefied biogasThe major expansion and modernization of Gasum’s biogas plant in Topinoja, Turku has been completed. The plant was opened today, and commercial use of the plant started up. The expansion of

2020 Bulkers Ltd. (2020) – Commercial update and key information relating to the cash distribution for October 2020

Hamilton, Bermuda, November 12, 2020 Commercial update: In October 2020, the Company achieved average time charter equivalent earnings of approximately US$22,400 per day, gross. The Company’s two vessels trading on index-linked time charter earned approximately US$33,600 per day, gross, including average daily scrubber benefits of approximately US$1,300 per day. The Company’s six vessels trading on fixed time charter earned approximately US$18,700 per day, gross, including average daily scrubber benefits of approximately US$1,100 per day for three of the vessels. The Baltic 5TC

Ideagen Reveals Trading Since April Ahead of Last Year Despite Coronavirus and Makes Board Changes

· Trading update for six months to Oct 31, 2020 anticipates ARR (Annual Recurring Revenue) growth of 20% and adjusted EBITDA growth of 25% · Julian Clough joins Board as Non-Executive DirectorA global supplier of regulatory and compliance solutions, Ideagen Plc, has today released another very positive interim trading update. The trading update reveals that despite operating in a difficult global environment because of the coronavirus pandemic, Ideagen looks to have succeeded in increasing its ARR and adjusted EBITDA by 20% and 25% respectively. The ARR book (which is the

2020 Bulkers Ltd. (2020) - Results for the third quarter

Hamilton, Bermuda, November 12, 2020 2020 Bulkers Ltd (2020) (“2020 Bulkers” or the “Company”), today announced its unaudited financial and operating results for the three and nine months ended September 30, 2020. Key events during the third quarter of 2020 · The Company reported net profit of US$4.8 million and EBITDA of US$10.6 million for the third quarter of 2020. · Achieved average time charter equivalent earnings of approximately US$22,100, per day, gross. · In September 2020, the Company paid dividends of US$0.01 per share for the month of July, 2020. · In

Etrion Releases Third Quarter 2020 Results

November 12, 2020, Geneva, Switzerland – Etrion Corporation (“Etrion” or the “Company”) (TSX: ETX) (OMX: ETX), an  independent renewable power producer, released today its condensed consolidated interim financial statements and related management’s discussion and analysis (“MD&A”) for the three and nine months ended September 30, 2020. Q3-20 HIGHLIGHTS Operational · Etrion produced 17.0 Gigawatt-hours (“GWh”) of electricity from the Company’s 57-megawatt (“MW”) portfolio comprising 11 solar power plant sites in Japan. Production was in line with forecast but 7.2% below the same

WntResearch publishes quarterly report Q3 2020

The first part of the WntResearch Q3 report can be read in English below and the complete Swedish Q3 report is attached.THIRD QUARTER (JULY-SEPTEMBER 2020) · Operating income amounted to MSEK 0 (0) · Costs amounted to MSEK 5.2 (7.3) · The result before and after taxes amounted to MSEK -5.2 (-7.3) · Earnings per share amounted to SEK -0.10 (-0.29) THE FIRST NINE MONTHS OF THE YEAR(JANUARY-SEPTEMBER 2020) · Operating income amounted to MSEK 0 (0) · Costs amounted to MSEK 15.4 (17.1) · The result before and after taxes amounted to MSEK -15.4 (-17.1) · Earnings

Another metro line win for KONE in China

KONE Corporation, press release, November 12, 2020 KONE Corporation, a global leader in the elevator and escalator industry, has won an order to supply 187 elevators and escalators to Metro Line 9 in Northwest China’s Xi’an, an important cultural, industrial and educational center in the region and one of the oldest cities in the entire country. Xi'an Metro Line 9 will run southwest to northeast between Fangzhicheng and Qinhan Avenue via 15 stations. The 30.6-kilometer-long line will also travel through the Lintong University City. After completion, line 9 will help to relieve

Scania partners with ENGIE and EVBox for charging solutions

The French global energy and services group ENGIE, and its subsidiary EVBox Group, are joining forces with Scania to offer transport providers in 13 European countries a customised and complete e-mobility solution.Charging is a prerequisite for electrifying transport. For transport providers in urban and some regional applications, depot charging will in many cases be sufficient. Many transport providers are therefore examining depot charging, but discovering that finding the right charging solutions is a complex  matter. For more advanced routes and as the electrification journey

Metso Outotec launches high-capacity Larox [® ]FFP3716 filter for sustainable tailings filtration

Metso Outotec Corporation’s press release on November 12, 2020, at 09:00 a.m. EETMetso Outotec is introducing a new high-capacity filter for demanding tailings applications. Extending the product family line of the FFP filters, the new Larox[®] FFP3716 filter comes with compact plate pack design and smart automation, redefining the overall standard in reliability, capacity and safety in tailings filtration. Combined with Metso Outotec’s optimized filtration plant design, the FFP3716 filter offers a reliable and cost-efficient long term solution for tailings management even in challenging

ASSA ABLOY´s divestiture of CEDES in Switzerland to capiton AG completed

ASSA ABLOY has closed the sale of its sensor technology business CEDES in Switzerland to capiton AG. CEDES is a leading sensor technology company in the elevator and door industry. CEDES was established in 1986 and has some 320 employees. The company is headquartered in Landquart, Switzerland. Sales in 2019 amounted to about 51 MEUR. The transaction will have a neutral effect on ASSA ABLOY´s operating margin. The divestiture will be de-consolidated from ASSA ABLOY as of November 2020.  For more information, please contact:Nico Delvaux, President and CEO, tel. no: +46 8 506

Interim report

January 1 – September 30, 2020The third quarter in figures · Net sales amounted to TSEK 2,287 (1,940). · The loss after tax amounted to TSEK 7,350 (9,868). · The loss per share amounted to SEK 0.20 (0.59). · The cash flow from current operations was negative in the amount of TSEK 6,974 (10,264). · The gross margin reached 52.7% (53.4%). · Electrode sales volume increased by 46% and reached 6,924 (4,752) units. Repeat sales of electrodes to existing customers increased by 57%. The first nine months in figures · Net sales amounted to TSEK 6,466 (6,476). · The

Everfuel signs frame agreement with Hexagon Purus and orders six hydrogen trailers for commercialization of zero emission mobility

Herning, Denmark, 12 November 2020 – Everfuel A/S has signed a multi-year frame agreement with Hexagon Purus for supply of hydrogen trailers designed exclusively to Everfuel specifications as part of the company’s strategy to connect the entire green hydrogen value chain, from production to consumption through core solutions for distribution and fueling supported by data driven optimization.  At signing of the frame agreement, Everfuel has ordered six hydrogen trailers for delivery in 2021. Everfuel will be the first to apply a customized version of Hexagon Purus’ newly designed hydrogen

Keliber and Kokkolan Energia confirm agreement on the site of the chemical plant

Keliber and Kokkolan Energia have confirmed a 30-year lease agreement for a 12.5-hectare site of the Keliber chemical plant to be built in the Kokkola Industrial Park. “We are very pleased with the good cooperation with Kokkolan Energia. We have an excellent construction site in the chemical industrial area with a high level of infrastructure and service offering. The area's focus on the circular economy and safety as well as in port, rail and vehicle traffic will serve our needs excellently,” says Hannu Hautala, CEO of Keliber. “We are pleased that we confirmed the agreement with

Hexagon Purus enters frame agreement with Everfuel, supporting commercialization of zero-emission hydrogen transport in Europe

Hexagon Purus has signed a multi-year master frame agreement with Everfuel to deliver multiple units of newly designed 45-foot, hydrogen distribution systems. The systems will be used to transport hydrogen to refueling stations serving hydrogen fuel cell electric passenger car fleets (e.g. taxis), trucks and buses, driving the transition to green hydrogen in several European cities. At signing, Everfuel ordered its first six distribution units under the new frame agreement. The master frame agreement covers design, production and delivery of hydrogen distribution systems for Everfuel

Interim report July – September 2020

Third quarter in brief ·Net sales amounted to 10.5 million SEK (12.0), which means a reduction in sales of -12 percent. · Operating profit amounted to -0.1 million SEK (3.4). · Profit for the period amounted to -0.2 million SEK (2.5). · Earnings per share amounted to -0.05 SEK (0.62).  First nine months in brief ·Net sales for the first nine months amounted to 32.9 million SEK (35.2), which means a reduction in sales of -6 percent. · Operating profit amounted to -2.2 million SEK (9.5). · Profit for the period amounted to -2.3 million SEK (7.2). ·

SimCorp reports revenue of EUR 310m and EBIT margin of 21% for the first nine months of 2020

Company Announcement no. 39/2020 Q3 2020 highlights: · In Q3 2020, four new SimCorp Dimension deals were signed, of which · Two deals were included in order intake and revenue · One deal was included in order intake, but revenue recognition has been deferred · For one deal, both order intake and revenue recognition have been deferred. · Order intake was EUR 21.7m, an increase of EUR 2.6m or 13.6% compared with Q3 2019. · Reported revenue was EUR 100.2m, a decrease of 14.7% compared with Q3 2019, due to a very strong Q3 2019 and revenue recognition of two new

Strong financial position, but quarter affected by Covid-19

The third quarter: July – The nine-month period: JanuarySeptember – September · Net sales amounted to · Net sales increased 5258 MSEK (292). percent to 931 MSEK (887). · Order intake amounted · Order intake amounted toto 142 MSEK (199). 703 MSEK (997). · Order backlog · Operating profit increasedamounted to 1,294 MSEK 10 percent to 113 MSEK (103).(1,557). · Net profit after tax · Operating profit increased 8 percent to 83 MSEKamounted to 29 MSEK (31). (77). · Net profit after

Skanska signs additional contracts for office improvements in western USA for about USD 198 M, about SEK 1.7 billion

Skanska has signed additional contracts with an existing client for improvements to their corporate office in the western USA. The contract is a joint venture with Skanska Balfour Beatty, and is worth USD 395 M. Skanska’s part is worth about USD 198 M, about SEK 1.7 billion, which will be included in the US order bookings for the fourth quarter of 2020.Construction is underway and is scheduled for completion in the fourth quarter of 2023. Skanska is one of the leading construction- and development companies in USA, specializing in building construction, civil infrastructure and

There are no items matching the current filter
There are no more items matching the current filter
Back to top